← Evidence map

ArticleCancer discovery2018

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

Ilirjana Bajrami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

80 papers cite itlatest 60 shown

2018
…
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29610289